Human Health
Read more at: Human Health
Swissmedic grants operating licence for new radiopharmaceutical production facility
From research to production – the new pharmaceutical lab at PSI supplies neighbouring hospitals with novel cancer drugs.
Making it easier to differentiate mirror-image molecules
Researchers have shown that mirror-image substances – so-called enantiomers – can be better distinguished using helical X-ray light.
European map of aerosol pollution can help improve human health
Researchers have measured and determined the sources of aerosol pollution at 22 locations in Europe.
Nominated: High-precision X-rays of breast tissue
Employing high-resolution X-rays to diagnose breast cancer – PSI researchers nominated for the European Inventor Award.
How to find anti-cancer agents
PSI researchers have developed a new substance that disables a vital protein in the cell skeleton.
Asthma: diagnosis in a single breath
PSI is involved in the development of a breath test that can be used to diagnose asthma. Imad El Haddad explains why such a test could be extremely useful – especially for children.
New, better coronavirus rapid test
The test identifies different virus variants and improves disease prognosis.
Millions in funding for brain and quantum research
The European Research Council approves PSI projects for the development of a quantum computer and brain research worth about 5 million euros.
More insight into how vision works
PSI scientists have shed light on the structure of an important component of the eye: CNG ion channels whose job is to relay optical signals to the brain.
The power of protons
This gallery presents five people who have been treated at the PSI's Center for Proton Therapy.
KSB and PSI forge a common research path
Kantonsspital Baden and the Paul Scherrer Institute PSI have signed a cooperation agreement.
Effective combination cancer treatment
Combining two chemotherapeutic drugs inhibits tumour growth.
New catalysts for pharmaceutical companies
In partnership with Roche, PSI scientists are developing new, potentially more efficient catalysts for manufacturing active substances for drug therapies.
Proton therapy: a success story that started 25 years ago
25 November 1996: a world first for PSI’s Center for Proton Therapy in treating a cancer patient using the spot-scanning technique.
A first for Switzerland: proton therapy to treat lung cancer
On 9 November 2021 a lung cancer patient was given proton therapy at the Paul Scherrer Institute PSI for the first time in Switzerland.
New active agent against parasites
PSI researchers identify potential active agent against several unicellular parasites – including the pathogens that cause malaria and toxoplasmosis.
Protein distancing
PSI researchers have developed a new method to attach proteins to the surface of virus-like particles.
Novel and emerging medical radionuclides
Better treatment for disseminated cancer.
Tracking down unreported Coronavirus cases
The University Hospital of Zurich uses proteins made at PSI for Europe’s first large-scale serology study on coronavirus prevalence in Switzerland.
PSI: advancing in the fight against Covid-19
Crystal structure analysis, computer models, cell cultures – to pursue research on Sars-CoV-2, PSI is exploring many avenues. An overview.